Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-24-196476
Filing Date
2024-08-08
Accepted
2024-08-08 07:21:26
Documents
2
Effectiveness Date
2024-08-08

Document Format Files

Seq Description Document Type Size
1 S-8 POS d875514ds8pos.htm S-8 POS 22109
2 EX-23.1 d875514dex231.htm EX-23.1 1682
  Complete submission text file 0001193125-24-196476.txt   24863
Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Filer) CIK: 0001785530 (see all company filings)

EIN.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-270764 | Film No.: 241186047
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)